MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma

Abstract Background MicroRNAs play crucial roles in tumorigenesis and tumor progression. miR-770 has been reported to be downregulated in several cancers and affects cancer cell proliferation, apoptosis, metastasis and drug resistance. However, the role and underlying molecular mechanism of miR-770...

Full description

Bibliographic Details
Main Authors: Jun-feng Zhang, Jian-shui Zhang, Zhao-hua Zhao, Peng-bo Yang, Sheng-feng Ji, Nan Li, Qin-dong Shi, Jing Tan, Xi Xu, Cang-bao Xu, Ling-yu Zhao
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-018-0694-9
_version_ 1819153351888076800
author Jun-feng Zhang
Jian-shui Zhang
Zhao-hua Zhao
Peng-bo Yang
Sheng-feng Ji
Nan Li
Qin-dong Shi
Jing Tan
Xi Xu
Cang-bao Xu
Ling-yu Zhao
author_facet Jun-feng Zhang
Jian-shui Zhang
Zhao-hua Zhao
Peng-bo Yang
Sheng-feng Ji
Nan Li
Qin-dong Shi
Jing Tan
Xi Xu
Cang-bao Xu
Ling-yu Zhao
author_sort Jun-feng Zhang
collection DOAJ
description Abstract Background MicroRNAs play crucial roles in tumorigenesis and tumor progression. miR-770 has been reported to be downregulated in several cancers and affects cancer cell proliferation, apoptosis, metastasis and drug resistance. However, the role and underlying molecular mechanism of miR-770 in human glioma remain unknown and need to be further elucidated. Methods The expression of miR-770 in glioma tissues and cell lines was measured by quantitative real-time PCR (qRT-PCR) to explore the association of miR-770 expression with clinicopathological characteristics. The expression of CDK8 was detected by qRT-PCR and Western blotting in glioma tissues. A target prediction program and a dual-luciferase reporter assay were used to confirm that CDK8 is a target gene of miR-770. MTT and cell counting assays were used to assess the effect of miR-770 on glioma cell proliferation. The cell cycle distribution and apoptosis were examined by flow cytometry. CDK8 siRNA and overexpression were used to further confirm the function of the target gene. Results We demonstrated that miR-770 expression was downregulated in human glioma tissues and cell lines. The overexpression of miR-770 inhibited glioma cell proliferation and cell cycle G1-S transition and induced apoptosis. The inhibition of miR-770 facilitated cell proliferation and G1-S transition and suppressed apoptosis. miR-770 expression was inversely correlated with CDK8 expression in glioma tissues. CDK8 was confirmed to be a direct target of miR-770 by using a luciferase reporter assay. The overexpression of miR-770 decreased CDK8 expression at both the mRNA and protein levels, and the suppression of miR-770 increased CDK8 expression. Importantly, CDK8 silencing recapitulated the cellular and molecular effects observed upon miR-770 overexpression, and CDK8 overexpression eliminated the effects of miR-770 overexpression on glioma cells. Moreover, both exogenous expression of miR-770 and silencing of CDK8 resulted in suppression of the Wnt/β-catenin signaling pathway. Conclusions Our study demonstrates that miR-770 inhibits glioma cell proliferation and G1-S transition and induces apoptosis through suppression of the Wnt/β-catenin signaling pathway by targeting CDK8. These findings suggest that miR-770 plays a significant role in glioma progression and serves as a potential therapeutic target for glioma.
first_indexed 2024-12-22T15:03:49Z
format Article
id doaj.art-57815f2dda7a4636858e097f098f9956
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-22T15:03:49Z
publishDate 2018-12-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-57815f2dda7a4636858e097f098f99562022-12-21T18:22:03ZengBMCCancer Cell International1475-28672018-12-0118111310.1186/s12935-018-0694-9MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in gliomaJun-feng Zhang0Jian-shui Zhang1Zhao-hua Zhao2Peng-bo Yang3Sheng-feng Ji4Nan Li5Qin-dong Shi6Jing Tan7Xi Xu8Cang-bao Xu9Ling-yu Zhao10Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi’an Medical UniversityDepartment of Human Anatomy, Histology and Embryology, Xi’an Jiaotong University Health Science CenterDepartment of Human Anatomy, Xi’an Medical UniversityDepartment of Human Anatomy, Histology and Embryology, Xi’an Jiaotong University Health Science CenterDepartment of Human Anatomy, Histology and Embryology, Xi’an Jiaotong University Health Science CenterDepartment of Neuropathology, The First Affiliated Hospital of Xi’an Jiaotong UniversityThe First Affiliated Hospital of Xi’an Jiaotong UniversityThe First Affiliated Hospital of Xi’an Jiaotong UniversityShaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi’an Medical UniversityShaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi’an Medical UniversityDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science CenterAbstract Background MicroRNAs play crucial roles in tumorigenesis and tumor progression. miR-770 has been reported to be downregulated in several cancers and affects cancer cell proliferation, apoptosis, metastasis and drug resistance. However, the role and underlying molecular mechanism of miR-770 in human glioma remain unknown and need to be further elucidated. Methods The expression of miR-770 in glioma tissues and cell lines was measured by quantitative real-time PCR (qRT-PCR) to explore the association of miR-770 expression with clinicopathological characteristics. The expression of CDK8 was detected by qRT-PCR and Western blotting in glioma tissues. A target prediction program and a dual-luciferase reporter assay were used to confirm that CDK8 is a target gene of miR-770. MTT and cell counting assays were used to assess the effect of miR-770 on glioma cell proliferation. The cell cycle distribution and apoptosis were examined by flow cytometry. CDK8 siRNA and overexpression were used to further confirm the function of the target gene. Results We demonstrated that miR-770 expression was downregulated in human glioma tissues and cell lines. The overexpression of miR-770 inhibited glioma cell proliferation and cell cycle G1-S transition and induced apoptosis. The inhibition of miR-770 facilitated cell proliferation and G1-S transition and suppressed apoptosis. miR-770 expression was inversely correlated with CDK8 expression in glioma tissues. CDK8 was confirmed to be a direct target of miR-770 by using a luciferase reporter assay. The overexpression of miR-770 decreased CDK8 expression at both the mRNA and protein levels, and the suppression of miR-770 increased CDK8 expression. Importantly, CDK8 silencing recapitulated the cellular and molecular effects observed upon miR-770 overexpression, and CDK8 overexpression eliminated the effects of miR-770 overexpression on glioma cells. Moreover, both exogenous expression of miR-770 and silencing of CDK8 resulted in suppression of the Wnt/β-catenin signaling pathway. Conclusions Our study demonstrates that miR-770 inhibits glioma cell proliferation and G1-S transition and induces apoptosis through suppression of the Wnt/β-catenin signaling pathway by targeting CDK8. These findings suggest that miR-770 plays a significant role in glioma progression and serves as a potential therapeutic target for glioma.http://link.springer.com/article/10.1186/s12935-018-0694-9miR-770CDK8GliomaProliferationCell cycle
spellingShingle Jun-feng Zhang
Jian-shui Zhang
Zhao-hua Zhao
Peng-bo Yang
Sheng-feng Ji
Nan Li
Qin-dong Shi
Jing Tan
Xi Xu
Cang-bao Xu
Ling-yu Zhao
MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
Cancer Cell International
miR-770
CDK8
Glioma
Proliferation
Cell cycle
title MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
title_full MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
title_fullStr MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
title_full_unstemmed MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
title_short MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
title_sort microrna 770 affects proliferation and cell cycle transition by directly targeting cdk8 in glioma
topic miR-770
CDK8
Glioma
Proliferation
Cell cycle
url http://link.springer.com/article/10.1186/s12935-018-0694-9
work_keys_str_mv AT junfengzhang microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT jianshuizhang microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT zhaohuazhao microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT pengboyang microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT shengfengji microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT nanli microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT qindongshi microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT jingtan microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT xixu microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT cangbaoxu microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma
AT lingyuzhao microrna770affectsproliferationandcellcycletransitionbydirectlytargetingcdk8inglioma